Back to Journals » Blood and Lymphatic Cancer: Targets and Therapy » Volume 7

Review

Use of carfilzomib in second-line therapy and beyond for relapsed multiple myeloma

       
Total article views   HTML views PDF downloads Totals
11,361 Dovepress* 11,361+ 1,028 12,389
Totals 11,361 1,028 12,389
*Since 19 July 2017

View citations on Google Scholar